How We Are Responding to COVID-19

The Ajinomoto Group contributes to the Summer Vacation Children’s Food Support Box project

Ajinomoto Bio-Pharma Services and Humanigen Expand Manufacturing Agreement to Support Fill Finish for Investigational COVID-19 Therapeutic, Lenzilumab, Nearing Completion of Phase 3 Study

Ajinomoto Group Indonesian affiliate holds webinar on health benefits of reducing salt intake

Ajinomoto Group Indonesian affiliate shapes their corporate communications for relevance and resonance with their customers’ lifestyles during the pandemic

Ajinomoto Group Malaysian affiliate delivers caring messages to social media followers

Ajinomoto Group Peruvian affiliate donates food to 25,000 affected by COVID-19

Ajinomoto Group Brazilian affiliate launches videos on wellness

Ajinomoto Philippines Corporation Supports Frontliners with aminoVITAL®

Ajinomoto Group Malaysian affiliate continues spread love & care through donation to community

Ajinomoto Group Brazilian affiliate donates 28 tons of products and distributes more than 32,000 liters of alcohol

Ajinomoto Group Thai affiliate donates money and products to 5 hospitals worth USD 160,000

Ajinomoto Bio-Pharma Services Signs Manufacturing Agreement with Humanigen for Lenzilumab, Currently in FDA-Approved Phase III Study for COVID-19